Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

ScienceAlert
sciencealert.com > this-week-in-science-a-grim-measles-milestone-a-lifespan-limit-and-more

This Week in Science: A Grim Measles Milestone, a Lifespan Limit, And More

12+ hour, 55+ min ago   (326+ words) This Week in Science: A galactic flip, 'programmable heat', and much more! First up: Measles cases in the US have just passed a 'grim milestone': 2026 has already beaten 2025's total, reaching the highest numbers in 35 years....

Newswise
newswise.com > articles > bioactive-nanomaterials-help-the-immune-system-find-hidden-tumors

Bioactive nanomaterials help the immune system find hidden tumors

16+ hour ago   (342+ words) | Newswise Newswise Bioactive nanomaterials help the immune system find hidden tumors Schematic illustration of bioactive nanomaterials developed by our group for enhanced cancer immunotherapy. Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do…...

EurekAlert!
eurekalert.org > news-releases > 1137518

Finding what it takes to make a white blood cell could lead to new cancer treatment

1+ day, 5+ hour ago   (674+ words) image: An image of human leukemia cells captured by Raquel Espin Palazon, an associate professor genetics, development and cell biology at Iowa State University. view more AMES, Iowa — In leukemia’s most aggressive forms, the blood cell factories in our bone…...

Oncodaily - Oncology News
oncodaily.com > science > gregory-lesinski

Gregory Lesinski: Winship Team Publishes Novel CAR/VIPRa T-Cell Therapy in Science - OncoDaily

1+ day, 5+ hour ago   (356+ words) Gregory Lesinski: Winship Team Publishes Novel CAR/VIPRa T-Cell Therapy in Science / Abhijay Mudigonda, Abir Muhuri, Andrew M. Johnson, Antonio B. Ward,, Abhijay Mudigonda, Abir Muhuri, Andrew M. Johnson, Antonio B. Ward, Anupam Patgiri, Benjamin G Barwick, Brad Heller, cancer, CAR T-cell therapy, Christopher…...

EurekAlert!
eurekalert.org > news-releases > 1137510

A yolk sac-derived hepatic γδ T cell subpopulation develops in a hematopoietic stem cell- and thymus-independent manner

1+ day, 5+ min ago   (359+ words) EurekAlert! A population of yolk sac-derived hepatic γδT cells develops in a thymus- and hematopoietic stem cell-independent manner. Credit: HIGHER EDUCATION PRESS Concurrently with and prior to the emergence of hematopoietic stem cells within the intraembryonic aorta, various types of…...

Zenopa
zenopa.com > us > news > kobe-ipsc-derived-t-cells-shrink-solid-tumours-in-mice

Kobe iPSC-Derived T Cells Shrink Solid Tumours in Mice - Life Science Industry News - Zenopa US

1+ day, 4+ hour ago   (168+ words) Looks like you’re on the US site. Choose another location to see content specific to your location Use our advanced search tool to help find your next job in the US, EU or UK. Send us your CV and requirements…...

@Tech_Networks
technologynetworks.com > cancer-research > news > off-the-shelf-mass-producible-immune-cells-fight-tumors-414955

Off-the-Shelf, Mass-Producible Immune Cells Fight Tumors

1+ day, 15+ hour ago   (559+ words) Technology Networks...

Pork Business
porkbusiness.com > news > husker-scientists-pioneer-breakthrough-swine-vaccine-innovation

Husker Scientists Pioneer Breakthrough Swine Vaccine Innovation

1+ day, 3+ hour ago   (511+ words) Husker scientists have developed a new swine influenza vaccination technique whose low cost and adaptability can greatly strengthen disease protection. This progress, part of the University of Nebraska–Lincoln’s overall focus on livestock vaccination innovation, directly benefits the state’s $5 billion,…...

EurekAlert!
eurekalert.org > news-releases > 1137466

Designing T-cell engagers: Trade-offs between activity and safety

1+ day, 8+ hour ago   (353+ words) T-cell engagers (TCEs) are an emerging class of immunotherapeutics that have demonstrated considerable clinical efficacy across a range of tumor types. However, their clinical application remains constrained by the challenge of balancing antitumor activity with acceptable safety, which is particularly…...

@genbio
genengnews.com > topics > cancer > colorectal-cancer-targeted-with-mass-produced-ipsc-derived-allogeneic-t-cells

Colorectal Cancer Targeted with Mass-Produced iPSC-Derived Allogeneic T Cells

1+ day, 3+ hour ago   (601+ words) Genetic Engineering and Biotechnology News Researchers at Kobe University have generated off-the-shelf, mass-producible induced pluripotent stem cell (iPSC)-derived gamma delta T cells (γδT cells) that in a small preclinical study suppressed tumor growth in mouse colorectal cancer (CRC) xenograft…...